Related references
Note: Only part of the references are listed.Elimination of fluorescent protein immunogenicity permits modeling of metastasis in immune-competent settings
Candice A. Grzelak et al.
CANCER CELL (2022)
RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy
Tomasz Radaszkiewicz et al.
ELIFE (2021)
H3K27me3-mediated PGC1α gene silencing promotes melanoma invasion through WNT5A and YAP
Chi Luo et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Paradoxical Role for Wild-Type p53 in Driving Therapy Resistance in Melanoma
Marie R. Webster et al.
MOLECULAR CELL (2020)
Crosstalk with lung epithelial cells regulates Sfrp2-mediated latency in breast cancer dissemination
Marco Montagner et al.
NATURE CELL BIOLOGY (2020)
Changes in Aged Fibroblast Lipid Metabolism Induce Age-Dependent Melanoma Cell Resistance to Targeted Therapy via the Fatty Acid Transporter FATP2
Gretchen M. Alicea et al.
CANCER DISCOVERY (2020)
BRN2, a POUerful driver of melanoma phenotype switching and metastasis
Mitchell E. Fane et al.
PIGMENT CELL & MELANOMA RESEARCH (2019)
Remodeling of the Collagen Matrix in Aging Skin Promotes Melanoma Metastasis and Affects Immune Cell Motility
Amanpreet Kaur et al.
CANCER DISCOVERY (2019)
Age-Related Changes in HAPLN1 Increase Lymphatic Permeability and Affect Routes of Melanoma Metastasis
Brett L. Ecker et al.
CANCER DISCOVERY (2019)
Wnt5a induces and maintains prostate cancer cells dormancy in bone
Dong Ren et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2019)
Wnt5a signaling induced phosphorylation increases APT1 activity and promotes melanoma metastatic behavior
Rochelle Shirin Sadeghi et al.
ELIFE (2018)
Cancer cell dormancy: mechanisms and implications of cancer recurrence and metastasis
Xiao-lei Gao et al.
ONCOTARGETS AND THERAPY (2017)
Key Roles of AXL and MER Receptor Tyrosine Kinases in Resistance to Multiple Anticancer Therapies
Marie Schoumacher et al.
CURRENT ONCOLOGY REPORTS (2017)
Emerging Biological Principles of Metastasis
Arthur W. Lambert et al.
CELL (2017)
In the Wnt-er of life: Wnt signalling in melanoma and ageing
Amanpreet Kaur et al.
BRITISH JOURNAL OF CANCER (2016)
Men and mice: Relating their ages
Sulagna Dutta et al.
LIFE SCIENCES (2016)
sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance
Amanpreet Kaur et al.
NATURE (2016)
Ligand Activation of TAM Family Receptors-Implications for Tumor Biology and Therapeutic Response
Viralkumar Davra et al.
CANCERS (2016)
Axl is required for TGF-β2-induced dormancy of prostate cancer cells in the bone marrow
Kenji Yumoto et al.
SCIENTIFIC REPORTS (2016)
Microphthalmia-associated transcription factor in melanoma development and MAP-kinase pathway targeted therapy
Claudia Wellbrock et al.
PIGMENT CELL & MELANOMA RESEARCH (2015)
NR2F1 controls tumour cell dormancy via SOX9-and RAR beta-driven quiescence programmes
Maria Soledad Sosa et al.
NATURE COMMUNICATIONS (2015)
Wnt5A promotes an adaptive, senescent-like stress response, while continuing to drive invasion in melanoma cells
Marie R. Webster et al.
PIGMENT CELL & MELANOMA RESEARCH (2015)
Differential TAM receptor-ligand-phospholipid interactions delimit differential TAM bioactivities
Erin D. Lew et al.
ELIFE (2014)
Mechanisms of disseminated cancer cell dormancy: an awakening field
Maria Soledad Sosa et al.
NATURE REVIEWS CANCER (2014)
MERTK controls melanoma cell migration and survival and differentially regulates cell behavior relative to AXL
Kathryn A. Tworkoski et al.
PIGMENT CELL & MELANOMA RESEARCH (2013)
Biology of the TAM Receptors
Greg Lemke
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2013)
Hypoxia Induces Phenotypic Plasticity and Therapy Resistance in Melanoma via the Tyrosine Kinase Receptors ROR1 and ROR2
Michael P. O'Connell et al.
CANCER DISCOVERY (2013)
Wnt5a Regulates Midbrain Dopaminergic Axon Growth and Guidance
Brette D. Blakely et al.
PLOS ONE (2011)
Cancer stem cells versus phenotype-switching in melanoma
Keith S. Hoek et al.
PIGMENT CELL & MELANOMA RESEARCH (2010)
A genomic screen identifies TYRO3 as a MITF regulator in melanoma
Shoutian Zhu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Wnt5A/CaMKII signaling contributes to the inflammatory response of macrophages and is a target for the antiinflammatory action of activated protein C and interleukin-10
Claudia Pereira et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Expression of secreted frizzled related protein 1, a Wnt antagonist, in brain, kidney, and skeleton is dispensable for normal embryonic development
Brune Trevant et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2008)
MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification
Juergen Cox et al.
NATURE BIOTECHNOLOGY (2008)
Statistical significance for genomewide studies
JD Storey et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma
AT Weeraratna et al.
CANCER CELL (2002)
Share Paper
